PNPLA3 Genotyping Predicts NASH Severity Using Histological and Serological Markers of Injury

被引：0
|
作者：
Argo, Curtis K. [1 ]
Patrie, James T. [2 ]
Lackner, Carolin [3 ]
Bao, Yongde [4 ]
Pramoonjago, Patcharin [4 ]
Caldwell, Stephen [1 ]
机构：
[1] Univ Virginia Hlth Syst, Div Gastroenterol & Hepatol, Charlottesville, VA USA
[2] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA
[3] Med Univ Graz, Dept Pathol, Graz, Austria
[4] Univ Virginia, Dept Pathol Biotissue Repository, Charlottesville, VA USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1504
引用
收藏
页码：897A / 897A
页数：1
相关论文
共 50 条
  • [1] Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH
    Bruschi, Francesca V.
    Tardelli, Matteo
    Herac, Merima
    Claudel, Thierry
    Trauner, Michael
    LIVER INTERNATIONAL, 2020, 40 (05) : 1098 - 1110
  • [2] SEROLOGICAL MARKERS OF CYTOSKELETAL INJURY AND INSULIN METABOLISM COLLECTIVELY PREDICT HISTOLOGICAL ACTIVITY IN NASH
    Argo, Curtis K.
    Northup, Patrick G.
    Jayakumar, Saumya
    Al-Osaimi, Abdullah M.
    Patrie, James T.
    Shah, Neeral L.
    Intagliata, Nicolas
    Lackner, Carolin
    Caldwell, Stephen
    HEPATOLOGY, 2011, 54 : 1133A - 1133A
  • [3] CC Genotype of PNPLA3 Polymorphism is Protective for Nonalcoholic Steatohepatitis (NASH)
    Guider, Julie
    Caldwell, Stephen H.
    Argo, Curtis K.
    HEPATOLOGY, 2013, 58 : 502A - 503A
  • [4] CARRIAGE OF RS738409 IN PNPLA3 IS POSITIVELY ASSOCIATED WITH THE SEVERITY OF HISTOLOGICAL DAMAGE IN PATIENTS WITH ALCOHOLIC HEPATITIS
    Atkinson, S. R.
    Forlano, R.
    Manousou, P.
    Grove, J.
    Aithal, G.
    McQuillin, A.
    Quaglia, A.
    Thursz, M. R.
    Goldin, R.
    Morgan, M. Y.
    ALCOHOL AND ALCOHOLISM, 2017, 52
  • [5] PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease
    Tortora, Raffaella
    Rispo, Antonio
    Alisi, Anna
    Imperatore, Nicola
    Crudele, Annalisa
    Ferretti, Francesca
    Nobili, Valerio
    Miele, Luca
    Gerbino, Nicolo
    Caporaso, Nicola
    Morisco, Filomena
    NUTRIENTS, 2018, 10 (09)
  • [6] A FREQUENT PNPLA3 VARIANT PREDICTS DISEASE COURSE IN PRIMARY SCLEROSING CHOLANGITIS
    Gotthardt, D.
    Friedrich, K.
    Rupp, C.
    Steinebrunner, N.
    Sauer, P.
    Weiss, K. H.
    Stiehl, A.
    Schirmacher, P.
    Stremmel, W.
    Runz, H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S556 - S556
  • [7] PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease
    Salameh, Habeeb
    Raff, Evan
    Erwin, Angelika
    Seth, Devanshi
    Nischalke, Hans Dieter
    Falleti, Edmondo
    Burza, Maria Antonella
    Leathert, Julian
    Romeo, Stefano
    Molinaro, Antonio
    Corradini, Stefano Ginanni
    Toniutto, Pierluigi
    Ulrich, Spengler
    Daly, Ann
    Day, Christopher P.
    Kuo, Yong-Fang
    Singal, Ashwani K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (06): : 846 - 856
  • [8] Pancreatic injury, genetic variation of PNPLA3, and risk of pancreatic cancer
    Aly, Mohammed
    Sahin, Ibrahim Halil
    Li, Donghui
    Khalil, Mohamed Fahd
    Chang, Ping
    Fogelman, David R.
    Javle, Milind M.
    Abbruzzese, James L.
    Hassan, Manal
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [9] LANIFIBRANOR IMPROVES LIVER HISTOLOGY AND MARKERS OF CARDIOMETABOLIC HEALTH IN PATIENTS WITH NASH INDEPENDENT OF PNPLA3 GENOTYPE: A RETROSPECTIVE ANALYSIS OF THE NATIVE STUDY
    Griffel, Louis H.
    Francque, Sven
    Abdelmalek, Manal F.
    Huot-Marchand, Philippe
    Baudin, Lucile Dzen Martine
    Junien, Jean Louis
    Broqua, Pierre
    Cooreman, Michael
    HEPATOLOGY, 2023, 78 : S1202 - S1203
  • [10] PNPLA3 RS738409 POLYMORPHISM PREDICTS THE DEVELOPMENT AND THE SEVERITY OF HEPATIC STEATOSIS, BUT NOT METABOLIC SYNDROME, IN PATIENTS WITH CELIAC DISEASE
    Imperatore, N.
    Tortora, R.
    Rispo, A.
    Alisi, A.
    Crudele, A.
    Ferretti, F.
    Nobili, V.
    Miele, L.
    Gerbino, N.
    Di Martino, V.
    Caporaso, N.
    Morisco, F.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E222 - E222
12345